1. Catalan, V.B., Kuo, C., Rajapaksa, R., Duault, C., Andor, N., Czerwinski, D., Levy, R., Levy, S. CD81 is a novel immunotherapeutic target for B cell lymphoma. JEM (2019). In press.
  2. Chen, J., Lau, B., Andor, N., Grimes, S., Handy, C., Wood Bouwens, C., Ji, HP. Single-cell transcriptome analysis identifies distinct cell types and niche signaling in a model of early gastric cancer development. Scientific Reports. doi: 10.1038/s41598-019-40809-x (2019).
  3. Andor, N.*, Simonds, E.*, Czerwinski, D., Chen, J., Grimes, S., Wood-Bouwens, C., Zheng, G., et al. Single-cell RNA-Seq of lymphoma cancers reveals a diverse landscape of malignant B cell types and co-expression of T cell immune checkpoints. Blood. doi: 10.1182/blood-2018-08-862292 (2019).
  4. Xia, LC., Ai, D., Lee, H., Andor, N., Li, C., Zhang, NR., Ji, HP. SVEngine: an efficient and versatile simulator of genome structural variations with features of cancer clonal evolution. Gigascience. doi: 10.1093/gigascience/giy081 (2018).
  5. Lorber, T., Andor, N., Dietsche, T., Perrina, V., Juskevicius, D., Pereira, K., Greer, S. U., Krause, A., Mueller, D., Savic, S., Lardinois, D., Barrett, M.T., Ruiz, C., Bubendorf, L. Exploring the Spatiotemporal Genetic Heterogeneity in Metastatic Lung Adenocarcinoma using a nuclei flow-sorting approach. The Journal of Pathology. doi: 10.1002/path.5183 (2018).
  6. Daynac, M., Chouchane, M., Collins, H., Murphy, N., Andor, N., Niu, J., Fancy, S., Stallcup, W., Petritsch, C. Lgl1 controls NG2 endocytic pathway to regulate oligodendrocyte differentiation and asymmetric cell division and gliomagenesis. Nature Communications. doi: 10.1038/s41467-018-05099-3. NCOMMS-17-28094B (2018).
  7. Andor, N., Maley, C. C. & Ji, H. P. Genomic Instability in Cancer: Teetering on the Limit of Tolerance. Cancer Res. doi:10.1158/0008-5472. CAN-16-1553 (2017).
  8. Andor, N., Graham, T., Jansen, M., Xia, LC., Aktipis, CA., Petritsch, C., Ji, HP., Maley, CC. Pan-cancer analysis of the extent and consequences of intra-tumor heterogeneity. Nature Medicine., 22, 105–113 (2016).
  9. Andor, N., Harness, J. V., Müller, S., Mewes, H. W. & Petritsch, C. EXPANDS: expanding ploidy and allele frequency on nested subpopulations. Bioinformatics. 30, 50–60 (2014).
  10. 1Hashizume, R., Andor, N., Ihara, Y., Lerner, R., James, C. D., et al. Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma. Nature Medicine. 10.1038/nm.3716 (2014).
  11. Sugiarto, S., Persson, A., Gonzalez-Munoz, E., Waldhuber, M., Lamagna, C., Andor, N., Hanecker, P., et al. Asymmetry-defective oligodendrocyte progenitors are glioma precursors. Cancer Cell. (20), 328-340 (2011). ​ ​


  12. Andor, N.*, Lau, B.*, Catalanotti, C., Kumar, V., Sathe, A., Belhocine, K., Wheeler, T., et al. Joint single cell DNA-Seq and RNA-Seq of gastric cancer reveals subclonal signatures of genomic instability and gene expression. doi: https://doi.org/10.1101/445932 (2019).​ ​
  • Selected press
  • Intratumour heterogeneity — a game of snakes and ladders. David Killock. Research Highlight Nature Reviews Clinical Oncology. January 2016.
  • Cancer’s mutational sweet spot identified by Stanford researchers. Krista Conger. Scope. December 2015.

  • * Authors contributed equally